Perrigo Company plc - PRGO Operatsion marja

Perrigo Corp (PRGO) kompaniyasining korporativ logotipi

Malakali texnologlar tajribasi va modernizatsiya qilingan avtomatlashtirilgan zavod quvvatlaridan foydalangan holda, Perrigo Company plc (PRGO) mahsulot ishlab chiqarishning uzluksizligini ta'minlaydi. GURU.Markets platformasidagi operatsion rentabellik biznesning samaradorligini aks ettiradi, bunda 4.60 ushbu parametrning qiymatini ifodalaydi. Kompaniya Private Label segmentida yetakchilik qiladi va Walmart kabi yirik chakana savdo tarmoqlariga hamyonbop generik dori vositalari alternativlarini yetkazib beradi.

PRGO: Perrigo Operatsion foyda bo'yicha marjinallik 04.07.2022 - 19.11.2026

Perrigo Company plc - tahliliy kesimlar va asosiy koʻrsatkichlar (PRGO)

- narx va narxlar bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning har tomonlama tahlili:PRGO, perrigo.com
Perrigo Corp brendining mahsuloti

Perrigo Company plc (PRGO) ning chakana savdo zanjirlariga chuqur integratsiyalashuvi B2B buyurtmalarining barqaror oqimini ta'minlaydi, bu esa operatsion marja tendentsiyasida aks etgan. Ushbu ko'rsatkich operatsion daromadning tushumga nisbati sifatida hisoblanadi va moliyaviy xarajatlar hamda soliqlardan oldingi xarajatlarni boshqarish samaradorligini o'lchaydi, bu esa investorlarga biznes modelining haqiqiy barqarorligini va asosiy ishlab chiqarishning daromadliligini baholash imkonini beradi.

Perrigo Company plc raqobatchilari

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|Alvotech Biopharmaceuticals - Operatsion marja|Operatsion faoliyat rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Operatsion rentabellik|anipharmaceuticals.com - Operatsion foyda normasi|Sotuvning operatsion marjasi MNKD|AMPH: Operatsion foyda normasi|Operatsion rentabellik pacira.com (PCRX)|Operatsion marja ARS Pharma (SPRY)|Theravance Biopharma - Sotuvning operatsion marjasi|Operatsion foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Tectonic Therapeutic|TNXP: Operatsion marja|SXT China (SXTC) - Operatsion marja|Operatsion rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Invizyne (EXOZ)|ORMP - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.